Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 CAD | -3.23% | -7.98% | -55.22% |
14/05 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.22% | 1.85Cr | |
+64.14% | 6.26TCr | |
-1.34% | 4.12TCr | |
+44.76% | 4.03TCr | |
-8.93% | 2.79TCr | |
+13.35% | 2.62TCr | |
-21.87% | 1.91TCr | |
+4.92% | 1.31TCr | |
+25.29% | 1.23TCr | |
+28.25% | 1.21TCr |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer